607
Views
2
CrossRef citations to date
0
Altmetric
Foreword

Expert Review of Neurotherapeutics: recent stroke highlights

Pages 175-178 | Published online: 09 Jan 2014

References

  • Carandang R, Seshadri S, Beiser A et al. Trends in incidence, lifetime risk, severity, and 30-day mortality of stroke over the past 50 years. JAMA296(24), 2939–2946 (2006).
  • Hacke W, Kaste M, Bluhmki E et al.; ECASS investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N. Engl. J. Med.359(13), 1317–1329 (2008).
  • Tsivgoulis G, Alexandrov AV. Timeframe for thrombolysis in acute ischaemic stroke. Lancet372(9646), 1275–1276 (2008).
  • Schumacher HC, Bateman BT, Boden-Albala B et al. Use of thrombolysis in acute ischemic stroke: analysis of the Nationwide Inpatient Sample 1999 to 2004. Ann. Emerg. Med.50(2), 99–107 (2007).
  • Levine SR, McConnochie KM. Telemedicine for acute stroke: when virtual is as good as reality. Neurology69(9), 819–820 (2007).
  • Demaerschalk BM, Miley ML, Kiernan TE et al.; STARR Coinvestigators. Stroke telemedicine. Mayo Clin. Proc.84(1), 53–64 (2009).
  • Thrall JH. Teleradiology. Part II. Limitations, risks, and opportunities. Radiology244(2), 325–328 (2007).
  • Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic and hemorrhagic stroke: incidence, prevalence, mortality, and risk factors. Neurol. Clin. (4), 871–895 (2008).
  • Taylor WR. Mechanical deformation of the arterial wall in hypertension: a mechanism for vascular pathology. Am. J. Med. Sci.316(3), 156–161 (1998).
  • Luepker RV, Arnett DK, Jacobs DR Jr et al. Trends in blood pressure, hypertension control, and stroke mortality: the Minnesota Heart Survey. Am. J. Med.119(1), 42–49 (2006).
  • Sacco S, Marini C, Totaro R et al. A population-based study of the incidence and prognosis of lacunar stroke. Neurology66(9), 1335–1338 (2006).
  • Schwamm LH, Fonarow GC, Reeves MJ et al. Get with the guidelines-stroke is associated with sustained improvement in care for patients hospitalized with acute stroke or transient ischemic attack. Circulation119(1), 107–115 (2009).
  • Adams HP Jr. Secondary prevention of atherothrombotic events after ischemic stroke. Mayo Clin. Proc.84(1), 43–51 (2009).
  • Sacco RL, Adams R, Albers G et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Circulation113(10), E409–E449 (2006).
  • Gorelick PB. Primary prevention of stroke: impact of healthy lifestyle. Circulation118(9), 904–906 (2008).
  • Joutel A, Favrole P, Labauge P et al. Skin biopsy immunostaining with a Notch3 monoclonal antibody for CADASIL diagnosis. Lancet358(9298), 2049–2051 (2001).
  • Saiki S, Sakai K, Saiki M et al. Varicose veins associated with CADASIL result from a novel mutation in the Notch3 gene. Neurology67(2), 337–339 (2006).
  • Dichgans M, Markus HS, Salloway S et al. Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol.7(4), 310–318 (2008).
  • Schneider LS. Does donepezil improve executive function in patients with CADASIL? Lancet Neurol.7(4), 287–289 (2008).
  • Peters N, Freilinger T, Opherk C et al. Enhanced L-arginine-induced vasoreactivity suggests endothelial dysfunction in CADASIL. J. Neurol.255(8), 1203–1208 (2008).
  • Kusaba T, Hatta T, Kimura T et al. Renal involvement in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). Clin. Nephrol.67(3), 182–187 (2007).
  • Gosk-Bierska I, Wysokinski W, Brown RD Jr et al. Cerebral venous sinus thrombosis: incidence of venous thrombosis recurrence and survival. Neurology67(5), 814–819 (2006).
  • Sébire G, Tabarki B, Saunders DE et al. Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome. Brain128(Pt 3), 477–489 (2005).
  • Khealani BA, Wasay M, Saadah M et al. Cerebral venous thrombosis: a descriptive multicenter study of patients in Pakistan and Middle East. Stroke39(10), 2707–2711 (2008).
  • Smith R, Hourihan MD. Investigating suspected cerebral venous thrombosis. Br. Med. J.334(7597), 794–795 (2007).
  • Roach ES. Cerebral venous sinus thrombosis: to treat or not to treat? Arch. Neurol.65(7), 987–988 (2008).
  • Philips MF, Bagley LJ, Sinson GP et al. Endovascular thrombolysis for symptomatic cerebral venous thrombosis. J. Neurosurg.90(1), 65–71 (1999).
  • Hedman LD, Sullivan JE, Hilliard MJ, Brown DM. Neuromuscular electrical stimulation during task-oriented exercise improves arm function for an individual with proximal arm dysfunction after stroke. Am. J. Phys. Med. Rehabil.86(7), 592–596 (2007).
  • Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch. Intern. Med.167(9), 921–927 (2007).
  • Ripley DL, Seel RT, Macciocchi SN, Schara et al. The impact of diabetes mellitus on stroke acute rehabilitation outcomes. Am. J. Phys. Med. Rehabil.86(9), 754–761 (2007).
  • Kittner SJ, White LR, Losonczy KG, Wolf PA, Hebel JR. Black–white differences in stroke incidence in a national sample. The contribution of hypertension and diabetes mellitus. JAMA264(10), 1267–1270 (1990).
  • Williams LS, Rotich J, Qi R et al. Effects of admission hyperglycemia on mortality and costs in acute ischemic stroke. Neurology59(1), 67–71 (2002).
  • Worthley MI, Shrive FM, Anderson TJ, Traboulsi M. Prognostic implication of hyperglycemia in myocardial infarction and primary angioplasty. Am. J. Med.120(7), 643.e1–e7 (2007).
  • Woo J, Lam CW, Kay R et al. The influence of hyperglycemia and diabetes mellitus on immediate and 3-month morbidity and mortality after acute stroke. Arch. Neurol.47(11), 1174–1177 (1990).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.